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Abstract
Background: Individuals with major depressive disorder (MDD) process information with a bias towards negative
stimuli. However, little is known on the link between vulnerability to MDD and brain functional anomalies
associated with stimulus bias.
Methods: A cohort of 38 subjects, of which 14 were patients with acute MDD and 24 were healthy controls (HC),
were recruited and compared. The HC group included 10 healthy participants with a first degree family history of
depression (FHP) and 14 volunteers with no family history of any psychiatric disease (FHN). Blood oxygen level
dependence signals were acquired from functional magnetic resonance imaging (fMRI) during performance in a
dot-probe task using fearful and neutral stimuli. Reaction times and the number of errors were also obtained.
Results: Although MDD patients and HC showed no behavioral difference, the MDD group exhibited smaller
activation in the left middle cingulum. The MDD group also showed smaller activation in the left insula when
compared to the HC group or the FHN group. Finally, FHP participants exhibited higher activation in the right
Heschl’s gyrus compared to FHN participants.
Conclusions: The present study shows that family risk for MDD is associated with increased activation in the
Heschl’s gyrus. Our results also suggest that acute MDD is linked to reduced activation in the insula and anterior
cingulate cortex during processing of subliminal, not recognizable, masked fearful stimuli. Further research should
confirm these results in a larger cohort of participants.
Introduction
Most conceptions of the relationship between mood and
emotions suggest that moods may potentiate matching
emotional reactions (for example, irritable mood facili-
tates angry reactions [1]). Depressed individuals show
more attention towards negative, anxiogenic stimuli [2]
which has also been found to be a risk factor for develop-
ing major depressive disorder (MDD) [3]. Importantly,
functional magnetic resonance imaging (fMRI) studies
have demonstrated activation anomalies in both MDD
patients and in patients at risk for depression during pre-
sentation of fearful images [4,5].
Interestingly, similar results have been found in healthy
individuals with family history of depression (FHP) when
compared to healthy individuals without any family his-
tory of the disease (FHN). FHP subjects exhibit impair-
ment in emotion recognition [6] and have been shown to
have higher amygdala and nucleus accumbens activation
in response to the presentation of fearful faces when
compared to age-matched FHN controls, in line with
previous findings showing that FHP subjects have signifi-
cantly elevated waking salivary cortisol when compared
to FHN subjects [7]. However, when face viewing is
accompanied by a constrained attention task (that is, hav-
ing to rate nose width on the face and subjective fear
while viewing the face), the differences between FHP and
FHN subjects disappear whilst prefrontal activity
increases [8]. This suggests that FHP subjects may be
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able to normalize emotion-related neural functions by
focusing their attention and that face-viewing with
unconstrained attention may leave room for aberrant
psychological processes associated with the risk for devel-
oping MDD [8]. However, both behavioral and event
related potential (ERP) studies have identified subtle defi-
cits in selective attention among FHP individuals that
may affect their ability to adequately regulate emotion
under stressful circumstances [9].
In order to investigate the interplay between cognitive
and emotion processing in both FHP and FHN partici-
pants, a masked emotion task combined with a cognitive
task known to elicit cognitive processing bias in MDD
might be useful to reveal performance differences
between these two groups. In this context, neuropsycho-
logical studies in a task called ‘dot-probe’ suggest that
depression is associated with an attentional bias towards
negative information [10] and that effortful cognitive
control of negative emotions can reduce the bias towards
fearful stimuli [11]. Neuroimaging dot-probe studies sug-
gest that unmasked fearful faces facilitate visual proces-
sing [12,13] and that the amygdala modulates fear
responses in the occipital cortex [14]. Further, previous
fMRI studies on participants performing in the dot-probe
task (for example, [12]) have shown that the amygdala
directs spatial attention to backward masked fearful faces
through a network of brain structures that include the
left anterior cingulate cortex (CC), right superior tem-
poral sulcus and right lingual gyrus [15-17]. Other
research in the dot-probe task has shown that individuals
with MDD cannot avoid attending negative information
in their environment [18] and FHP individuals attend
selectively to sad faces [19]. Importantly, there is evi-
dence that effortful control modulates the relationship
between negative affectivity and attentional bias in the
dot-probe task, with low levels of effortful control and
high levels of negative affectivity predicting a preference
for threat stimuli [11]. With respect to the fact that,
when viewing subliminal masked stimuli, participants do
not focus their attention on the masked stimuli, the dot-
probe task is highly interesting because it might elicit
activity associated with vulnerability to MDD [8]. How-
ever, to the best of our knowledge, little or no research
has investigated putative functional anomalies in the
brain showing during performance in this task in either
MDD or FHP individuals.
In the present study, we hypothesized that patients with
MDD compared to HC subjects, but also FHP subjects
compared to FHN subjects, exhibit differences in emo-
tional processing of fearful versus neutral stimuli when
attention is biased during performance in a dot-probe
task. Based on previous fMRI findings (for example, [17])
in a similar behavioral task [8,20-24], we selected the CC,
amygdala, insula and prefrontal cortex as primary regions




A cohort of 38 subjects aged between 18 and 65 was
recruited. The healthy family history positive subjects
(FHP, n = 10) were unaffected first-degree relatives of
patients formally diagnosed with MDD according to the
fourth edition of the Diagnostic and Statistical Manual of
Mental Disorders (DSM-IV) and treated at the South-
West Mental Health Services in Dublin, Ireland. How-
ever, the FHP subjects recruited were not the relatives of
the MDD patients that participated in the study. Family
history of MDD was assessed by a psychiatrist through a
structured interview. Participants were asked whether
any of their first degree relatives had been diagnosed
with a psychiatric disease or had ever displayed symp-
toms of psychosis. Healthy volunteers without a history
of psychiatric illness (FHN, n = 14) were recruited from
the local community via announcements. The MDD
group consisted of 14 patients with acute MDD attending
our clinical outpatient services (Table 1). Of these, 4 were
currently drug-free and came as new patients to our ser-
vice, three received escitalopram, one fluoxetine, two
venlafaxine, one venlafaxine plus mirtazapine, one sertra-
line plus mirtazapine, one sertraline, and one duloxetine
plus mirtazapine.
For all subjects, a structured written observer interview
and a structured interview carried out by two psychiatrists
were used to assess demographic variables and medical
history. Exclusion criteria were previous head injury with
loss of consciousness, cortisol medication in their medical
history, previous alcohol or substance abuse, co-morbidity
with other mental illnesses, personality disorders, neurolo-
gical or psychiatric disorder (Axis I or Axis II) or age over
65 years. No subject had ever received electroconvulsive
therapy before investigation or took any psychotropic
medications.
All participants included in the study filled out the fol-
lowing self- and observer-rated scales: the 21-item ver-
sion of the Hamilton Depression Rating Scale for
Depression [25], the Montgomery-Åsberg Depression
Rating Scale [26], Beck’s Depression Inventory [27] and
the Structured Clinical Interviews for DSM-IV (SCID)-I
[28] for psychiatric diseases and SCID-II [29] for person-
ality assessment.
Handedness was determined by the Edinburgh Hand-
edness Inventory [30]. Written informed consent was
obtained from all subjects subsequent to a detailed
description of the study. The study design, approved by
the ethics committee of the Adelaide and Meath Hospital
incorporating the National Children’s Hospital and St.
James’ Hospitals, was prepared in accordance with the
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ethical standards laid down in the Declaration of
Helsinki.
Statistical analysis of clinical and demographic
characteristics
Clinical and demographic data were analyzed using
SPSS-16. Differences in gender and handedness were
analyzed using Chi-square tests (see Table 1). Differ-
ences in age, weight and height were computed using a
one-way analysis of variance (ANOVA). As alcohol
intake (g/day) and the number of cigarettes smoked per
day were found to be non-normally distributed, medians
were calculated and a Kruskal-Wallis test was used to
evaluate statistical differences between groups.
Behavioral data
Behavioral measures analyzed included mean reaction
time (RT) and the number of errors (that is, an error
being made when the dot was indicated in the wrong
side of the screen). Two conditions were compared: ‘fear
same’ (dot and fearful face presented on the same side of
the screen) and ‘fear opposite’ (dot and fearful face pre-
sented on opposite sides of the screen). There were a
total of 19 ‘fear opposite’ trials and 31 ‘fear same’ trials
for each participant. These trials were randomly selected
by the presentation software. Unfortunately, due to a
recording failure during the scanning sessions, some
behavioral data were lost. Only the data that could be
fully retrieved were included in the analysis (see Table 2).
Both RTs and the number of errors for each condition
were submitted to an ANOVA. A Bonferroni test was
used for post hoc comparisons.
fMRI data acquisition
Functional images were acquired on a 3-Tesla MRI
scanner (Philips Achieva, The Netherlands). The MRI
protocol consisted of the acquisition of a high resolution
three-dimensional T1-weighted structural dataset








Gender (female/male) 4/10 6/4 9/5 4.1 2/36 0.12
Handedness (right/left/ambidextrous) 14/0/0 8/2/0 12/1/1 5 4/34 0.3
Mean SD Mean SD Mean SD F df P
Age (years) 35 9.4 33 10 41.2 10.3 2.2 2/36 ns
Weight (kg) 74 18 63.3 5 73.6 13 1.9 2/36 ns
Illness duration (years) - - - - 16 10 - - -
HDRS score 0.7 0.9 4.8 5.3 24.8 5 125 2/36 < 0.001a
Age of onset - - - - 25 11 - - -
Median MR Median MR Median MR 4.7 df P
Alcohol intake per week (g) 16 16 60 26 28 18 4.6 2/36 ns
Cigarettes per day 0 15 1 23.5 0 21 5.7 2/36 ns
aThere was a difference between the MDD patients and either the FHN (P < 0.001) or the FHP (P < 0.001) subjects in the HDRS; bF-score from analysis of
variance. df: degrees of freedom; MDD: patients with major depressive disorder; FHN: healthy participants without family history of MDD; FHP: healthy
participants with family history of MDD; HDRS: Hamilton Depression Rating Scale for Depression; ns: not significant; SD: standard deviation, Χ2: Chi-squared score,
MR: Mean Rank







Mean SD Mean SD Mean SD Fc df P
Neutral samea 4932 1076 4936 745 5342 606 0.402 2/20 0.67
Neutral oppositeb 4903 1406 4818 697 5455 466 0.6 2/20 0.56
Fear samea 4589 721 4767 690 5582 684 4.4 2/20 0.05
Fear oppositeb 5122 586 4734 710 5121 643.5 1.25 2/20 0.31
Fear (right+left) 4756 956 4728 700 5672 600 0.81 2/20 0.46
Neutral (right+left) 9835 2454 9754 1436 10797 1040 0.51 2/20 0.60
Number of errors 7 6.6 3.9 8 16.4 35 0.70 2/20 0.51
aDot and fearful face presented on the same side of the screen; bdot and fearful face presented in opposite sides of the screen; c F-score from analysis of
variance. df: degrees of freedom; MDD: patients with major depressive disorder; FHN: healthy participants without family history of MDD; FHP healthy participants
with family history of MDD; SD: standard deviation.
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[spoiled gradient recalled sequence with repetition time
(TR)/echo time (TE) = 8.5/3.9 ms and 1 mm spatial
resolution], followed by an fMRI experiment [spin-echo
echo-planar imaging (SE-EPI) sequence with TR/TE =
2000/35 ms, in-plane resolution = 3 × 3 mm, 4.8 mm
slice thickness, 304 dynamic scans each with 2 s
duration].
Twenty five slices [dynamic scan time: 304, field of view:
reference line: 230 mm, aperture: 230 mm, Fourier with a
Hanning window (FH): 120 mm] covered the whole brain.
Slices were positioned on the connecting line between the
anterior and posterior commissure.
Dot-probe task
Color mixed-race facial identities including 12 (6 male and
6 female) fearful and 12 (6 male and 6 female) neutral
expressions [31] were randomly presented on a screen. A
7th neutral female face from the same database was used
as a mask. Each trial started with a fixation cross lasting
between 1,000 and 2,500 ms. Next, a stimulus (randomly
selected from neutral and fearful stimuli) was presented
for 33 ms on the left or right visual field (LVF and RVF,
respectively) and immediately masked by two neutral faces
simultaneously presented (100 ms) on each visual field.
Projections of masks were followed by a LVF or RVF tar-
get dot (750 ms) presentation with a jittered (500 ms to
2,000 ms) inter-trial interval. Subjects were required to
respond as soon as possible by pressing a ‘right’ or ‘left’
button on a computer keyboard, according to the position
of the target dot on the visual field. All participants were
administered a practice trial. The total duration of the task
was 10 minutes.
fMRI data analysis
Standard preprocessing procedures were performed in
SPM8 (Wellcome Trust Centre for Neuroimaging). The
first six scans were not used to allow for T1 equilibration.
The EPI images were then realigned to the first volume in
order to correct for head movements. Realignment para-
meters were inspected visually to identify any potential
subjects with head movement > 4.8 mm (slice thickness).
Each participant’s structural image was co-registered to
the mean of the motion-corrected functional images using
a 12-parameter affine transformation. Image slice time
was corrected to TR/2. The structural images were seg-
mented according to the standard procedure in SPM8
[32]. Spatial normalization to standard 3 mm × 3 mm ×
3 mm Montreal Neurological Institute (MNI) space was
then applied to functional images in order to allow for
inter-subject analysis. Finally, these images were smoothed
using an 8 mm full width at half maximum Gaussian
kernel. Statistical parametric maps were calculated using a
general linear model based on a voxel-by-voxel method
[33].
First level single subject statistical parameter maps were
created for each condition using the general linear model
in SPM8. After parameter estimation, the following two
contrasts were created: ‘fear’ > ‘neutral’ (F > N) and ‘fear’ <
‘neutral’ (F < N). Subsequently, these were entered into a
full factorial second level analysis model using three
groups (MDD, FHP and FHN) as factors. Age and gender
were entered as cofactors. The statistical threshold was set
to P < 0.05, with whole brain family-wise error (FWE) cor-
rection for multiple comparisons. Moreover, we reported
differences with P < 0.001 in predefined regions of interest.
Results
Demographic data
The MDD group scored higher in the Hamilton Depres-
sion scale than either the FHN (P < 0.001) or FHP group
(P < 0.001). No age, gender or handedness difference was
found between groups (Table 1).
Behavioral data
There was no significant difference between groups for
either the RTs or the number of errors (Table 2).
fMRI data (Table 3)
Contrast F > N
MDD patients exhibited smaller activation than healthy
controls (HC) in the left middle cingulum (T = 3.82,
P = 0.041, FWE corrected for multiple comparisons)
and left insula (T = 4.19, P < 0.001, uncorrected), which
also showed a trend for significance after correction for
multiple comparisons (P = 0.072) (Figure 1). Smaller
activation in the left insula was also found in the MDD
group when compared to the FHN group (T = 4.43, P =
0.033, FWE corrected for multiple comparisons).
Further, MDD patients had smaller activation in the left
post-central gyrus when compared to FHN participants
(T = 3.59, P < 0.001, uncorrected), although this differ-
ence did not survive FWE correction. Finally, the FHP
group had greater activation in the right Heschl’s gyrus
when compared to the FHN group (T = 4.60, P = 0.018,
FWE corrected for multiple comparisons) (Figure 2).
Contrast F < N
The FHP group had smaller activation in the right
Heschl’s gyrus (T = 5.22, P = 0.002, FWE corrected for
multiple comparisons) when compared to the FHN
group.
Discussion
While being presented with masked fearful stimuli, our
participants showed significant differences in areas that
are thought to play a key role in emotion processing,
namely the CC and insula. Further, our results suggest a
link between family history of MDD and functional
anomalies in the Heschl’s gyrus.
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Table 3 Paired comparisons between healthy controls (HC, n = 24), family history negative healthy participants (FHN,
n = 14), family history positive healthy participants (FHP, n = 10) and patients with major depressive disorder (MDD,
n = 14)
Contrast Comparison Region Region of interest P (FWE correction) Ke T Puncorrected x y z
F > N MDD < HC Left middle cingulum 0.041 (cluster corr.) 71 3.82 < 0.001 -15 -28 37
Left insula 0.072 8 4.19 < 0.001 -27 29 7
MDD < FHN Left insula < 0.033 11 4.43 < 0.001 -27 29 7
Left post-central gyrus ns 29 3.59 < 0.001 -27 -28 37
MDD > FHN - ns - - ns - - -
MDD < FHP - ns - - ns - - -
MDD > FHP - ns - - ns - - -
FHP > FHN Right Heschl’s gyrus 0.018 17 4.60 < 0.001 51 -28 13
FHP < FHN - ns - - ns - - -
F < N FHP < FHN Right Heschl’s gyrus 0.002 26 5.22 < 0.001 51 -28 13
MDD < FHP - ns - - ns - - -
MDD > FHP - ns - - ns - - -
F > N: “fear” > “neutral” contrast; F < N: “fear” < “neutral” contrast; FWE: family wise error correction; Ke: number of significant voxels; ns: not significant; T: t-
value; x, y, z: coordinates in the Montreal Neurological Institute system.
Figure 1 Coronal and axial sections displaying activation
differences between major depressive disorder (MDD) patients
and healthy controls (HC) in the left middle cingulum (T =
3.82, PFWE = 0.041) and left insula (T = 4.19, P < 0.001,
uncorrected). FWE: whole brain family-wise error correction.
Figure 2 Coronal and axial sections displaying activation
differences between family history positive (FHP) and family
history negative (FHN) participants in the right Heschl’s gyrus
(T = 4.60, PFWE = 0.01). FWE: whole brain family-wise error
correction.
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MDD patients showed reduced activity in the left mid-
dle CC when compared to the HC group, adding to pre-
vious findings suggesting an important role of CC
anomalies in the diagnosis of anxiety disorders and/or
depression [34]. In particular, this effect was observed
when fearful facial expressions elicited stronger activa-
tion, in line with earlier fMRI research suggesting a role
for the CC in orienting spatial attention to crude threat
signals [8,17]. In this study, we found no effect in the
amygdalae for all participants, suggesting a more direct
involvement of the CC in attention recruitment during
performance in the dot-probe task. This result might
also agree with previous findings showing an involve-
ment of the CC in shaping emotional expectancy in
both healthy individuals and patients with MDD [35].
Interestingly, we found no effect in the prefrontal cor-
tex, which contrasts with previous research showing
prefrontal anomalies in both MDD and healthy partici-
pants with family history of MDD [8,24,36]. Our find-
ings might suggest that our version of the dot-probe
task is not sensitive to prefrontal activation anomalies in
either MDD or FHP subjects, in line with previous
research on the dot-probe task showing the involvement
of the anterior CC, amygdalae, temporal and occipital
cortices [12,13]. Although these results might need
replication, an important consideration is to be made
when comparing our data to previous findings in similar
experimental contexts: while in the study of Monk et al.
[8] participants were required to consciously shift their
attention towards a specific feature of the stimulus pre-
sented (that is, participants were asked to rate the size
of the nose in a given face), in the dot-probe task, sti-
mulus perception is subliminal (emotional stimuli are
masked by neutral stimuli). This might have an effect
on how attention is recruited and might explain why, in
our study, we detected no prefrontal effect. Previous
research [15,17,37] has shown that the CC plays a key
role in directing attention when an individual is not
conscious of an emotional facial stimulus being pre-
sented. Further, recent ERP findings suggest that back-
ward masked fearful face-elicited spatial attention
facilitates behavior and modulates the early stage of
facial processing [38].
Interestingly, when compared to the FHN group, the
FHP group exhibited activation differences in the right
Heschl’s gyrus. In this area, FHP participants had greater
activation for contrast F > N and smaller activation for
contrast F < N. The Heschl’s gyrus is a subregion of the
superior temporal gyrus that, apart from being function-
ally involved in auditory processing, plays an important
role in emotional processing, theory of mind and empa-
thy [39,40]. Volumetric reductions in this area have been
found in MDD patients, even after recovery from the
disease [41]. Moreover, similar results have also been
shown in bipolar disorder patients [42]. Our results
implicate activation differences in superior temporoparie-
tal areas between individuals with and without family his-
tory of MDD during exposure to fearful facial
expressions. As only the right hemisphere was involved,
our findings might also suggest a lateralization effect.
This is perhaps in line with previous fMRI research sug-
gesting a role of the right Heschl’s gyrus during exposure
to emotional (auditory) stimuli [43] and showing that the
activation of auditory processing regions specialized for
language, like the Heschl’s gyrus, can be detected during
performance in tasks requiring visual perception of the
human face [44]. This might support the belief that this
cortical area plays a role in acquired dynamic audiovisual
integration mechanisms in the left superior temporal sul-
cus [44]. In this context, our results suggest a non-task
specific role of the Heschl’s gyrus in facial emotion pro-
cessing, which is perhaps lost in MDD.
It is certainly interesting that MDD patients and FHP
participants showed activation anomalies in different corti-
cal areas, when compared to FHN participants. However,
in the present study, these two groups consisted of unre-
lated individuals and whether MDD affects functional
aberrances already detected before its onset in FHP sub-
jects should be determined by future longitudinal studies.
The present study has a number of limitations. The
subject sample was probably too small to reveal beha-
vioral differences across groups. Additionally, the total
number of HC participants was almost double than the
number of MDD patients. This surely had an effect on
our results. For example, our raw data suggested that
MDD patients made considerably more errors than the
HC group, although this could not be supported by sta-
tistical significance. Increasing the participant sample
and having a comparable number of HC versus MDD
participants would probably have yielded more definitive
results. Further research in a larger sample of participants
is also needed to confirm our RT analysis and compari-
sons (the RTs of some participants were lost due to a
system failure).
Importantly, in the present study, we did not include
images displaying faces conveying positive (happy) emo-
tions. For this reason, we cannot rule out that our fMRI
findings simply reflected brain activation associated with
the presentation of emotional stimuli. In this regard,
further fMRI research should aim at comparing brain acti-
vation relative to both happy and fearful faces. Participants
were asked after scanning whether they could recognize
subliminal images and confirmed that they did not detect
them. Employing a detection task within the session
would have been difficult, because participants already had
to respond to the dots they saw after the shortly presented
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face images (100 ms). Further, future studies should also
investigate correlations between behavioral and MRI data.
Quite a substantial limitation of the present study is also
represented by the inclusion of MDD patients with differ-
ences in medication which, as shown by previous fMRI
research (for example, [23,45]), can affect brain activation.
Finally, it also possible that the outcome of this research
was affected by our recruitment method. We selected FHP
participants as first-degree relatives of patients with well-
known recurrent depression, but who did not necessarily
take part in the study. As all the MDD patients recruited
were assessed by the same psychiatrists, selecting relatives
of MDD patients involved in the study might have con-
tributed to ascertain family history of the disease in FHP
participants. On the other hand, this would have intro-
duced a genetic bias, whose selective effect on MRI data
should be investigated in future research.
Conclusions
Our results suggest that, in the dot-probe task, FHP sub-
jects exhibit altered activity in the right Heschl’s gyrus
associated with subliminal presentation of fearful stimuli,
indicating that lateralized alteration in the functionality of
this cortical area could be associated with a higher risk of
becoming depressed, although this should be confirmed
by longitudinal studies on a larger population sample.
Moreover, in individuals with MDD, the CC might med-
iate a preference for negative emotions as delivered by
subliminally presented human faces. Further research is
surely needed to explore the correlation between cortical
and/or subcortical anomalies and behavioral responses in
a similar experimental setting and to investigate putative
therapeutic effects of psycho- and pharmacotherapy on
the activation anomalies we detected.
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